Clinical Trials Browser

OTHER × Lymphoma × pirtobrutinib × Clear all

NCT07285590 2025-12-16

IMCL-2023

Phase 2 Recruiting

Lymphoma, Lymphoma, Mantle-Cell

NCT07052695 2025-12-15

Mosunetuzumab for CLL MRD Clearance

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell